(Q56768701)

2

0 references

John O Praag

3

0 references

Joost L Knegjens

4

0 references

Sherif Y El Sharouni

5

0 references

Matthew Hatton

6

0 references

Astrid Keijser

7

0 references

Corinne Faivre-Finn

8

0 references

Suresh Senan

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

9

0 references

language of work or name

English

0 references

publication date

3 January 2015

0 references

January 2015

0 references

published in

The Lancet

0 references

volume

385

0 references

issue

9962

0 references

page(s)

36-42

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Small cell lung cancer: have we made any progress over the last 25 years?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Left behind? Drug discovery in extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Prophylactic cranial irradiation in extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Radiotherapy in small-cell lung cancer: lessons learned and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021

Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961085-0

7 January 2021